期刊文献+

藁本内酯抑制星形胶质细胞中NF-κB依赖的细胞因子的表达 被引量:6

Ligustilide inhibits NF-κB dependent cytokines upregulation in primary cultured astrocytes
下载PDF
导出
摘要 目的观察藁本内酯(LIG)对脂多糖(LPS)诱导的星形胶质细胞中促炎性细胞因子表达的抑制作用。方法将原代培养成功的星形胶质细胞随机分成四组,对照组(C组)、LPS组、LIG组、BAY组。C组未加入任何药物刺激细胞;LPS组加入浓度为1μg/ml的LPS刺激细胞6h;LIG组用浓度为50μM的LIG预孵育细胞30min后,再加入LPS刺激6h;BAY组用浓度为20μM的核转录因子(NF)-κB抑制剂BAY11-7082预孵育细胞30min后,再加入LPS刺激6h。采用Real-time PCR方法检测促炎性细胞因子白细胞介素(IL)-1β、肿瘤细胞坏死因子(TNF)-α、IL-6 mRNA的表达;采用Western blot方法检测pNF-κB p65的表达。结果与LPS组比较,C、LIG和BAY组IL-1β、TNF-α、IL-6mRNA的表达明显减少(P<0.05)。与LPS组比较,C、LIG组pNF-κB p65蛋白的表达明显降低(P<0.05)。结论藁本内酯可通过抑制原代培养的星形胶质细胞中NF-κB的活化来抑制LPS诱导的促炎症相关的细胞因子的表达。 Objective To observe the inhibition effect of ligustilide(LIG)on lipopolysaccharide(LPS)-induced pro-inflammatory cytokines expression in the primary cultured astrocytes.Methods The cultured astrocytes were divided randomly into four groups:control group(group C),groups LPS,LIG and BAY.Group C didn't receive any chemicals treatment;Group LPS was stimulated with LPS 1μg/ml for 6h;group LIG was preincubated with LIG 50μM for 30 min,and then stimulated with LPS for 6h;group BAY was preincubated with BAY11-7082 20μM for 30 min,and then stimulated with LPS for 6h.The IL-1!,TNF-α,IL-6mRNA expression was measured by Real-time PCR. The expression of pNF-κB p65 protein was detected by Western blot.Results Compared with group LPS,the IL-1!,TNF-α,IL-6mRNA expression was obviously decreased in groups C,LIG and BAY(P〈0.05).Compared with group LPS,the pNF-κB p65 protein expression was decreased in groups C,LIG and BAY(P〈0.05).Conclusion LIG inhibited the expression of pro-inflammatory cytokines by inhibiting NF-κB activation in the primary cultured astrocytes.
出处 《临床麻醉学杂志》 CAS CSCD 北大核心 2014年第11期1121-1124,共4页 Journal of Clinical Anesthesiology
基金 南通大学2013年国家级 省级大学生创新训练计划项目(201310304035Z) 南通大学博士科研启动基金项目(03080728)
关键词 藁本内酯 星形胶质细胞 细胞因子 核转录因子-ΚB Ligustilide Astrocytes Cytokines Nuclear transcription factor-κB
  • 相关文献

参考文献10

  • 1Ma Z, Bai L. Anti-inflammatory effects of Z-ligustilide nano- emulsior~ Inflarnmation,2013, 36(2)~294 299.
  • 2Su YW, Chiou WF, Chao SH, et al. Ligustilide prevents LPS-induced iNOS expression in RAW 264. 7 macrophages by preventing ROS production and down-regulating the MAPK, NF-kappaB and AP-1 signaling pathways. Int Immunop-harmacol,2011, 11(9) :1166-1172.
  • 3Du J, Yu Y, Ke Y, et al. Ligustilide attenuates pain behav- ior induced by acetic acid or formalin. J Ethnopharmacol, 2007, 112(1):211-214.
  • 4Zhao LX, Jiang BC, Wu XB, et al. Ligustilide attenuates in- flammatory pain via inhibition of NFκB-mediated ehemokines production in spinal astrocytes. Eur J Neurosci,2014:39(8) 1391-1402.
  • 5Wu K, Wang ZZ, Liu D, et al. Pharmacokinetics, brain dis- tribution, release and blood-brain barrier transport of Shu- naoxin pills. J Ethnopharmacol, 2014, 151(3) : 1133-1140.
  • 6Yirmiya R, Goshen I. Immune modulation of learning, mem- ory, neural plasticity and neurogenesis. Brain Behav Immun, 2011, 25(2):181-213.
  • 7Ramesh G, MacLean AG, Philipp MT. Cytokines and che mokines at the crossroads of neuroinflammation, neurodegen- eration, and neuropathic pain. Mediators Inflamm, 2013, 2013..480739.
  • 8Gao YJ, Ji RIL Targeting astrocyte signaling for chronic pain. Experimental Neurotherapeutics, 2010, 7 (4) : 482-493.
  • 9Kiguchi N, Kobayashi Y, Kishioka S. Chemokines and cyto- kines in neuroinflammation leading to neuropathie pain. Curr Opinion Pharmacol, 2012, 12(1) : 55-61.
  • 10Niederberger E, Geisslinger G. The IKK-NF-kappaB path- way: a source for novel molecular drug targets in pain thera py? FASEB J,2008, 22(10) :3432-3442.

同被引文献90

引证文献6

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部